The size and reputation of the Institute bring an enormous range of patients, including high-risk patients and those who benefit from other procedures prior to or in lieu of transplantation. Our spirit of collaboration and specialization is evident in our high survival rates, the products of a seamless integration of medical and, surgical services, as well as innovative immunosuppressive therapy.
The Institute's heart, liver, lung, kidney (renal), and pancreas transplant programs offer state-of-the-art therapies that can extend and dramatically improve the quality of life for transplant patients. From evaluation to post-operative follow-up, patients receive a seamless integration of multidisciplinary services that deliver the comprehensive and consistent care necessary for their well-being.
Along with excellence in clinical care, the Institute is committed to the ongoing progress of transplantation through rigorous scientific research. Its dedicated teams of surgeons and physicians are responsible for many of the significant advances made over the past several decades in transplant surgery and the maintenance of healthy organs. For example, the Institute has been on the forefront of developing and improving anti-rejection medications (immunosuppressants), minimally invasive surgery for living donors, and the FDA-approved Left Ventricle Assist Device (LVAD) that functions as a bridge to transplantation for those waiting for a new heart.
Please click on one of the links above to learn more about our heart, liver, lung, renal, and pancreas transplant centers.
